Bruker Corporation BRKR recently announced the successful installation and acceptance of a 1.2 GHz Avance Nuclear Magnetic Resonance (“NMR”) spectrometer at the Korea Basic Science Institute (“KBSI”).
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today announced the appointment of Mr. Thomas Bachmann as the new President of its Bruker BioSpin Group. Mr. Bachmann most recently ...
Bruker Corporation’s BRKR 1.2 GHz Ascend Nuclear Magnetic Resonance (NMR) spectrometer has been accepted at the Swiss High-field NMR Facility, operated jointly by the University of Basel, ETH Zürich, ...
Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: Th ...
At the 65th ENC (www.enc-conference.org), Bruker introduces the Ascend Evo 600, a novel compact 54 mm standard-bore 14.1 Tesla (600 MHz) NMR magnet, which features a full one-year liquid Helium ...
NewsMedical talks to Bruker BioSpin about how Chemspeed’s modular automation systems integrate with NMR technology to enable smarter, more autonomous labs. Chemspeed systems are known for their ...
Participating laboratories, or service providers, can maximize their instrument uptime by providing analytical services to clients in need, thereby reducing the total cost of ownership (TCO) of an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback